Clinical Trial Update: Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer [Phase 4]

View source ↗

Summary

Clinical trial update comparing nab-paclitaxel with docetaxel followed by anthracyclines and cyclophosphamide in neoadjuvant breast cancer (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Nab-paclitaxel (paclitaxel protein-bound)
• anthracyclines (anthracycline)

Snippet

Sponsor: Xijing Hospital | Conditions: Breast Cancer | Phase 4 | Status: UNKNOWN